Chronic Obstructive Pulmonary Disease (COPD) is a lung condition characterised by chronic respiratory symptoms that cause persistent, often progressive, airflow obstruction. Approximately 1.4 million people in England aged 40 or over have a COPD diagnosis with a further 500,000 undiagnosed.
N-Tidal is a point-of-care diagnostic medical device that can be used in the primary care pathway to identify and diagnose COPD patients. It combines the measurement of respiratory physiology using biomarkers and interpreting the data using diagnostic AI algorithms in real time. The device aims to reduce the need for secondary care spirometry confirmation and diagnosis of COPD.
Health Innovation Oxford and Thames Valley performed a barrier to adoption study using the lean assessment process methodology and engaged with key stakeholders working in the COPD diagnosis pathway to gain insights into the perceived usefulness, potential clinical benefits, acceptability and barriers to adoption of the device for this unmet clinical need.
